Detalhe da pesquisa
1.
Are We on the Same Page? Patient and Provider Perceptions About Exercise in Cancer Care: A Focus Group Study.
J Natl Compr Canc Netw
; 15(5): 588-594, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28476738
2.
Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study.
Invest New Drugs
; 32(1): 195-9, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23728919
3.
Biosimilar Use Among 38 ASCO PracticeNET Practices, 2019-2021.
JCO Oncol Pract
; 19(7): 516-522, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084324
4.
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care.
J Clin Oncol
; 39(2): 155-169, 2021 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33290128
5.
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer.
Lung Cancer
; 81(1): 138-41, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23628526
6.
A morphealike skin condition caused by Borrelia burgdorferi in an immunocompromised patient.
Mayo Clin Proc
; 81(9): 1259-60, 1263, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16970224
7.
Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.
J Thorac Oncol
; 3(9): 1018-25, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18758305
8.
Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer.
J Thorac Oncol
; 1(3): 218-25, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17409860